ClinicalTrials.govpublic full text
Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
hepatocellular carcinoma, sirolimus, mtor, hcc-recurrence free survival, liver transplant recipients, hcc recurrence free survival, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 994053
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.